36.67
+0.26(+0.71%)
Currency In USD
| Previous Close | 36.41 |
| Open | 36.24 |
| Day High | 36.98 |
| Day Low | 36.24 |
| 52-Week High | 38 |
| 52-Week Low | 24.05 |
| Volume | 2.24M |
| Average Volume | 3.81M |
| Market Cap | 15.85B |
| PE | 16.01 |
| EPS | 2.29 |
| Moving Average 50 Days | 36.17 |
| Moving Average 200 Days | 34.25 |
| Change | 0.26 |
If you invested $1000 in Royalty Pharma plc (RPRX) since IPO date, it would be worth $908.8 as of October 30, 2025 at a share price of $36.67. Whereas If you bought $1000 worth of Royalty Pharma plc (RPRX) shares 3 years ago, it would be worth $920.66 as of October 30, 2025 at a share price of $36.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Royalty Pharma Declares Fourth Quarter 2025 Dividend
GlobeNewswire Inc.
Oct 17, 2025 12:15 PM GMT
NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on December
Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025
GlobeNewswire Inc.
Oct 09, 2025 8:15 PM GMT
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2025 financial results on Wednesday, November 5, 2025 before the U.S. financial markets open. The company will host
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
GlobeNewswire Inc.
Sep 29, 2025 12:15 PM GMT
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that the independent directors of the Board have unanimously appointed Dr. Ted W. Love, an independent director since 2020, as Lead Independent Director.